Zoe B Siemienski

Capsid Serotype and Timing of Injection Determines AAV Transduction in the Neonatal Mice Brain

D. Borchelt, T. Golde, P. Cruz, 2013, PloS one.

Microglia-specific targeting by novel capsid-modified AAV6 vectors

T. Golde, P. Cruz, Paramita Chakrabarty, 2016, Molecular therapy. Methods & clinical development.

Substantially elevating the levels of αB‐crystallin in spinal motor neurons of mutant SOD1 mice does not significantly delay paralysis or attenuate mutant protein aggregation

D. Borchelt, Zoe B Siemienski, Keith W Crosby, 2015, Journal of neurochemistry.

Heterogeneity of Matrin 3 in the developing and aging murine central nervous system

D. Borchelt, Jada Lewis, Abigail R Hernandez, 2016, The Journal of comparative neurology.

Analysis of spinal and muscle pathology in transgenic mice overexpressing wild-type and ALS-linked mutant MATR3

D. Borchelt, Jada Lewis, Zoe B Siemienski, 2018, Acta Neuropathologica Communications.

Retraction Note: Transgenic mice overexpressing the ALS-linked protein Matrin 3 develop a profound muscle phenotype

D. Borchelt, M. Swanson, L. Notterpek, 2017, Acta Neuropathologica Communications.

Transgenic mice overexpressing the ALS-linked protein Matrin 3 develop a profound muscle phenotype

D. Borchelt, M. Swanson, L. Notterpek, 2016, Acta Neuropathologica Communications.

Viral expression of ALS-linked ubiquilin-2 mutants causes inclusion pathology and behavioral deficits in mice

Nikolaus R. McFarland, T. Golde, P. Cruz, 2015, Molecular Neurodegeneration.

Experimental mutagenesis of huntingtin to map cleavage sites: different outcomes in cell and mouse models.

D. Borchelt, Andrew T. N. Tebbenkamp, L. Tessarollo, 2014, Journal of Huntington's disease.